The University of Waikato, Hamilton, New Zealand; The University of Auckland, Auckland, New Zealand. PURPOSE: This study aims to examine the differences in characteristics, treatment and survival between Asian and European women diagnosed with stage I-III breast cancer in New Zealand. METHODS: The...
Journal of Epidemiology and Community Health, 63(Suppl 2), 13. doi:http://dx.doi.org/10.1002/cncr.25127,Hill S, Sarfati D, Blakely T, Robson B (2009) Ethnicity and cancer treatment in New Zealand: do Maori patients get a worse deal? J Epidemiol Community Health 63:13...
A growing gap in cancer survival is emerging between New Zealand and comparator countries such as Australia and Canada. While survival rates are impacted by early detection, receipt of high quality and timely anti-cancer treatment is clearly key. Several clinical, policy, and structural factors ...
National Health and Medical Research Council and Australian Cancer Network Clinical Practice Guidelines: Non-melanoma Skin Cancer: Guidelines for Treatment and Management in Australia. Canberra, Australia: National Health and Medical Research Council; 2003 25. von Fragstein MSilverman JCushing AQuilligan ...
Sarah was given the new drug and her tumors shrunk! She was inremission[rɪˈmɪʃ(ə)n]for over 2 years. In 2010, the tumors returned, and Sarah traveled back to Boston for further drug treatment, which w...
Back in 1925, Otto Warburg wouldn’t have suspected the special role of mitochondria in cancer. They had been discovered during his lifetime, but the importance of their role had yet to be documented. Ozone, as a treatment, doesn’t simply send more oxygen to the cell; it stimulates the...
We hypothesize that several concomitant medications taken prior to diagnosis may modify the natural course of BC. The main objective of this study designated ADRENALINE (Atlas of Drugs, Comorbidities, and Cancer Treatment Survival Interaction), is to analyze the impact of medication use in the six ...
Molecular biology, Translational oncology, Experimental cancer therapeutics, Novel druggable targets and novel treatment strategies in breast cancer and thymic cancer Deputy Editor Ilkka Ilonen, MD, Ph.D, FEBTS Helsinki University Hospital Heart and Lung Center, Helsinki, Finland Thoracic Surgery Associate...
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated wit
Castration-resistant prostate cancer Treatment switch Response Progression Circulating tumour cells Abiraterone 1. Introduction The past decade has seen an increase in the therapeutic armamentarium against metastatic prostate cancer, with agents proving survival benefit both in the castrate-resistant (mCRPC) ...